方舟子说:实际使用效果证明美国疫苗有效而中国疫苗无效

1. 我觉得中国没有必要自己再公布三期试验结果。一是中国自己没有第一手数据,二是国外作过的数据不管是正面的,负面的都已经公布了。
2. 如果是我,或者是更外行一点儿的人说这话,有情可原。它不管怎么说是相关领域的博士,实在是贻笑大方。听听他对“疫苗反作用”的解释,哈哈灭活疫苗不但没有有效的抗体,反而有可能有些其它没有用的抗体。它当灭活疫苗是老太太腌酸菜啊。作为博士,应该知道引用数据或者例证要有可靠的出处,某记者说,某医院?12个打了疫苗的都感染,并且7个进ICU这么严重的事情,在这么多国家,这么大的试验范围内都没发现?要么这个是谣言,要么所有第三方国家都在帮助中国作假。
3. 再听听他后面关于中国开始在国内推广疫苗的厥词,是他妈的人话吗?

公布结果和公布数据是不同的概念,这一点要搞明白。
 
都不要吵了,不能听方舟子瞎扯,我看视频里面关键证据就是秘鲁医院12个感染7个ICU,如果谁能找到这个新闻我就信肘子,找不到谁发消息问肘子要
 
标题说的很清楚,结果。


是带数据的结果。


这是数据:

As of December 16, 2020, there were 12,396 health workers over 18 years old enrolled. A total of 253 positive cases were collected during the observation period. After 14 days following vaccination with 2 doses of vaccine following a 0, 14 day schedule, the efficacy rate against diseases caused by COVID-19 was 50.65% for all cases, 83.70% for cases requiring medical treatment, and 100.00% for hospitalized, severe, and fatal cases.

There are two stages of the phase III clinical trial in Turkey. Participants comprised health care workers in the first stage (K-1) and the general population in the second stage (K-2), with all participants ranging from 18 to 59 years old. As of December 23, 2020, there were 918 participants enrolled in K-1 and 6,453 participants in K-2, for a total of 7,371 participants. Among them, 1,322 participants completed the two-dose vaccination and entered the 14-day observation period after receiving the second dose of the vaccination. Based on an analysis of 29 cases, the efficacy rate for COVID-19 prevention was 91.25% after 14 days following the two-dose vaccination, in adherence with the 0, 14 day schedule.
 
中国那么有钱,为什么还不如美国大方呢?早批准,卖的更多吧。



美国更富。
现在已经供不应求,不能卖得更多了。
 
现在都在抢疫苗哇,欧盟成员国之间都在抢。



中国疫苗在国际市场上价格最高。


Screenshot_20210404_222442.jpg
 
是带数据的结果。


这是数据:

As of December 16, 2020, there were 12,396 health workers over 18 years old enrolled. A total of 253 positive cases were collected during the observation period. After 14 days following vaccination with 2 doses of vaccine following a 0, 14 day schedule, the efficacy rate against diseases caused by COVID-19 was 50.65% for all cases, 83.70% for cases requiring medical treatment, and 100.00% for hospitalized, severe, and fatal cases.

There are two stages of the phase III clinical trial in Turkey. Participants comprised health care workers in the first stage (K-1) and the general population in the second stage (K-2), with all participants ranging from 18 to 59 years old. As of December 23, 2020, there were 918 participants enrolled in K-1 and 6,453 participants in K-2, for a total of 7,371 participants. Among them, 1,322 participants completed the two-dose vaccination and entered the 14-day observation period after receiving the second dose of the vaccination. Based on an analysis of 29 cases, the efficacy rate for COVID-19 prevention was 91.25% after 14 days following the two-dose vaccination, in adherence with the 0, 14 day schedule.

这要是数据,who 五分钟就审查完了……
 
有点脑子的人都会想想政治局常委为嘛不打
 
后退
顶部
首页 论坛
消息
我的